Rights and permissions
About this article
Cite this article
Levosalbutamol yields “economic advantages” in asthma, COPD. Pharmacoecon. Outcomes News 402, 8 (2003). https://doi.org/10.1007/BF03275940
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03275940